← Open Payments lookup

MICHAEL REUTTER: Open Payments

NPI 1639407414 · BERLIN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,671 in 112 payments from 27 companies in 2025. Trend: 2023 $1,455 · 2024 $1,363 · 2025 $1,671

Food & beverage: $1,671
CompanyPaymentsAmount
Lilly USA, LLC14$180
Amgen Inc.19$180
Kowa Pharmaceuticals America, Inc.12$145
Otsuka America Pharmaceutical, Inc.7$125
Ardelyx, Inc.6$120
Lundbeck LLC5$98
ABBVIE INC.5$84
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$82
Vanda Pharmaceuticals Inc.4$71
Bayer Healthcare Pharmaceuticals Inc.4$67

Products named: REXULTI, ZORYVE, OMVOH, IBSRELA, EVENITY, OTEZLA, FANAPT, Kerendia.

Industry payments across NJ — which companies pay providers there.